Clinical Study of a Novel Humanized CD70-Targeted CAR-T Cell Incorporating TLR2 for Advanced Renal Cell Carcinoma Therapy
NCT07113977
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
NOT_YET_RECRUITING
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Advanced Renal Cell Carcinoma
Interventions
BIOLOGICAL:
CAR-T(CD70)
Sponsor
Wei Guan